Eisai Co. and its subsidiaries are engaged in the manufacture and sale of pharmaceuticals, consumer health care products, diagnostic products, chemicals and food additives, and animal health products. Co. s products include antiallergy agent, osteoporosis treatment, gastritis/gastric ulcer medication, vitamins, food preservative, flavoring agent, and sweetening material. Co. is also engaged in the manufacture and sale of pharmaceutical production system and machines.
Quote | Eisai Co. Ltd. ADR (OTCMKTS:ESALY)
Last: | $61.51 |
---|---|
Change Percent: | -1.37% |
Open: | $62.35 |
Close: | $61.51 |
High: | $63.29 |
Low: | $61 |
Volume: | 331,859 |
Last Trade Date Time: | 01/30/2023 03:39:52 pm |
News | Eisai Co. Ltd. ADR (OTCMKTS:ESALY)
2023-12-05 03:58:10 ET Summary Investing in most current Alzheimer's drug companies is not recommended because they are not likely to modify the disease. Compounds that inhibit oxidative stress may only slow down the progression of Alzheimer's disease over the short term. Anav...
2023-07-03 06:49:30 ET Summary We check in on Catalyst Pharmaceuticals today as a lot has happened around the company since we last looked at it last summer. These include a major addition to the company's pipeline, challenges on the patent litigation front, and impressive organic...
Message Board Posts | Eisai Co. Ltd. ADR (OTCMKTS:ESALY)
Subject | By | Source | When |
---|---|---|---|
Big new now. Alzheimers number one enemy. | IPO$ | investorshub | 01/06/2023 7:38:48 PM |
whytestocks: $ESALY News Article - Biotech Stocks LLY, ESALY Gain on Biogen's Positive Trial Results | whytestocks | investorshangout | 09/28/2022 5:50:58 PM |
whytestocks: $ESALY News Article - Why Biogen, Lilly, and Prothena Stocks Are Skyrocketing Today | whytestocks | investorshangout | 09/28/2022 4:10:54 PM |
whytestocks: $ESALY News Article - Why Is Cassava Sciences (SAVA) Stock Heating Up Today? | whytestocks | investorshangout | 09/28/2022 3:20:54 PM |
whytestocks: $ESALY News Article - Eisai's Lecanemab Confirmatory Phase 3 Clarity AD Study Met Prima | whytestocks | investorshangout | 09/28/2022 1:55:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Eisai Co. Ltd. ADR Company Name:
ESALY Stock Symbol:
OTCMKTS Market:
Eisai's Initiatives for Developing New Medicines for Neglected Tropical Diseases and Malaria and Commitment for Funding to the 3rd Phase of Global Health Innovative Technology Fund Activities TOKYO, May 25, 2023 - (JCN Newswire) - Eisai Co., Ltd. has announced that it will grant a t...
Eisai Delivers New Data and Highlights Continued Progress of Oncology Portfolio and Pipeline at ASCO 2023 TOKYO, May 24, 2023 - (JCN Newswire) - Eisai Co., Ltd. announced today the presentation of research across various types of cancer from its oncology portfolio and pipeline durin...
Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer's Disease TOKYO and CAMBRIDGE, Mass., May 16, 2023 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that Health Canada has accepted a New Drug Submission (NDS) for lecanemab (b...